Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia - A Randomized Controlled Clinical Trial (SLEEPINS)

NCT04144231 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT04144231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04144231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia - A Randomized Controlled Clinical Trial (SLEEPINS)
Lead sponsor
Helsinki University Central Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 19, 2019
Completion date
September 6, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, schizoaffective disorder, schizophrenia